MinichMacGregor Wealth Management’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$968K Buy
+23,337
New +$939K 0.16% 60
2023
Q1
– Sell
-115
Closed -$3.15K – 287
2022
Q4
$3.15K Buy
+115
New +$3.06K ﹤0.01% 524

Other funds holding FTXH

MinichMacGregor Wealth Management's FTXH Position: Q3 2026 in Review

MinichMacGregor Wealth Management opened a new position in First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q3 2026: 23,337 shares worth $968K. The stake represents 0.16% of the portfolio and ranks #60 among its holdings. This is a return to the name: MinichMacGregor Wealth Management previously reported a position in FTXH as recently as Q4 2022.

MinichMacGregor Wealth Management first reported a position in FTXH in Q4 2022 and has held it in 2 quarters since. 23 funds tracked by Wall St. Rank hold FTXH as of Q3 2026.

  • MinichMacGregor Wealth Management held 23,337 shares of First Trust Nasdaq Pharmaceuticals ETF worth $968K as of Q3 2026.
  • First Trust Nasdaq Pharmaceuticals ETF was a new MinichMacGregor Wealth Management position in Q3 2026.
  • First Trust Nasdaq Pharmaceuticals ETF made up 0.16% of MinichMacGregor Wealth Management's portfolio in Q3 2026, its #60 holding.
  • MinichMacGregor Wealth Management first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q4 2022 and has held it in 2 quarters since.
  • 23 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q3 2026.

Based on MinichMacGregor Wealth Management's 13F filing for Q3 2026, filed 14 Oct 2026.